Advertisement

The Latest

Nevro in Menlo Park, Calif., a medical device company, has announced the issuance of four additional key patents related to the company's Senza(R) system and High-Frequency Spinal Cord Stimulation therapy.

Readmissions are a significant concern for hospitals, as they will receive cuts to their Medicare payments for higher-than-expected readmission rates for certain diagnoses.

Advertisement